Research Article

Iron Accumulation Is Not Homogenous among Patients with Parkinson’s Disease

Table 3

Different ROIs with high phase values among PD subjects.

PD patientsROI with highest ironAge (year)Sex
(M/F)
Phase value
Average of ROIs
Phase value
SN
Presenting symptoms
RLRLBradykinesiaTremorRigidity

1RN70F2160.312167.952221.502253.20LLL > R
2DN69F2165.372169.612236.432232.80R > LR, ChinR > L
3GM, RN54F2164.152161.732254.302239.10RR, ChinR
4WM65F2162.352166.622214.002229.80RR < L
5GP87F2203.232215.002273.562258.32R~LR
6SN, PUT82F2173.012170.202309.362289.93LLL
7GP76F2161.372170.462235.002239.55RRR
8GM, SN79M2179.542190.012307.742384.97RRR
9PUT, CN76F2176.812179.752253.782280.21LLL
10GP75M2187.802177.652251.212214.00L > RRL
11WM, DN63M2159.292158.282238.002217.60RRR
12THA76F2165.382167.632214.002232.00LLL

CN: caudate nucleus, GP: globus pallidus, PUT: putamen, RN: red nucleus, SN: substantia nigra, THA: thalamus, C-SN: caudal substantia nigra, DN: dentate nucleus, WM: white matter, GM: gray matter, M: male, F: female, L: left, and R: right.